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CRPAbstract Background: Acute lung injury (ALI) is associated with signiﬁcant mortality and mor-
bidity. C-reactive protein (CRP) level a marker of systematic inﬂammation is widely-used in numer-
ous clinical conditions, however little is known about the characteristics of CRP levels in patients
with ARDS and acute lung injury (ALI).
The aim of this work was to examine the plasma level of C-reactive protein (CRP) in patients
with acute lung injury (ALI) and its relationship with prognosis, outcome, and severity of illness.
Patients and methods: The study was carried out on 100 consecutive patients, who were admitted
to the Critical Care Medicine Departments in Alexandria Main University Hospital. Inclusion cri-
teria were patients were aged >18 years who had one or more of the acute lung injury (ALI) pre-
disposing conditions. Patients who developed ALI based on standard deﬁnition according to the
American–European consensus conference were examined for C-reactive protein levels measured
in serum (mg/dl) collected within 48 h after fulﬁllment of criteria.
Results: CRP levels were the highest in patients with complete recovery ranging between 190 and
233 mg/dl with a mean of 211.5 ± 30.406 mg/dl, modest in patients who recovered with residual
complications ranging between 107 and 120 with a mean of 111.33 ± 7.506 mg/dl, and lowest in
patients who died ranging between 35 and 106 with a mean of 79.55 ± 24.007 mg/dl. Higher
CRP levels were signiﬁcantly associated with better survival (P= 0.000). There was an inverse rela-
tionship between CRP levels and duration of mechanical ventilation while ICU stay increased as the
CRP levels increased. The relationships between CRP levels and both mechanical ventilation days
and ICU stay were statistically non signiﬁcant (P= 0.710 and 0.801 respectively). CRP levels were
lower in patients who developed multiorgan dysfunction syndrome (MODS) with a mean of
76.6 ± 28.778 mg/dl compared to a mean of 111.43 ± 59.332 mg/dl in patients who didn’t develop
MODS, this relationship was not statistically signiﬁcant (P= 0.060).d.
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226 A.A. Mahrous et al.Conclusions: Although CRP has widely been considered to be a marker of systemic inﬂamma-
tion, our ﬁndings show that higher levels of CRP are associated with decreased mortality, organ
failure, and need for mechanical ventilation among patients with ALI.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Introduction
Acute lung injury (ALI) and its severe form acute respiratory
distress syndrome (ARDS) are terms used to describe the pul-
monary response to a wide range of insults that lead to abnor-
malities in oxygenation with refractory hypoxemia and diffuse
radiographic shadowing of the lungs, and usually necessitate
invasive mechanical ventilation. These insults can be direct
or indirect; they are listed in Table 1 [1].
In 1967, Ashbaugh [2] ﬁrst described adult respiratory dis-
tress syndrome, now known as acute respiratory distress syn-
drome (ARDS).Deﬁnition
1. In 1994, North American–European consensus conference
(NAECC) on ARDS [3] agreed on standard deﬁnitions of
ARDS and an illness less severe than ARDS, namely, acute
lung injury (ALI).ed with ALI and ARDS [1].
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re, 18 mmHg
FiO2 ratio
lung injury: 6300
respiratory distress syndrome: 62
peciﬁedARDS is considered to be present in the sitting of bilateral
inﬁltrates on a chest radiograph, a PaO2/FiO2 <200, and a
pulmonary artery occlusion pressure 618 mmHg or no clinical
evidence of elevated left atrial pressure. ALI is deﬁned simi-
larly, with the difference being that the PaO2/FiO2 is <300.
Unlike earlier deﬁnition of ARDS, the PaO2/FiO2 is deﬁned
regardless of the level of positive end expiratory pressure
(PEEP) [4].
Although AECC deﬁnitions allowed for a concerted ALI/
ARDS research effort, the validity of the deﬁnition has been
criticized. For example, the vague nature of the term ‘‘acute,’’
vide intraobserver variation in ascertaining ‘‘bilateral radio-
graphic inﬁltrates’’, [5] and sensitivity of the PaO2/FiO2 ratio
criteria to small changes in positive end-expiratory pressure
(PEEP) [6] led to the recent revisiting of the AECC deﬁnition
and drafting of the Berlin deﬁnition of ARDS [7] (Table 2).
The Berlin criteria were unique in that they were iteratively
drafted and then empirically evaluated in order to provide a
deﬁnition that would be feasible, reliable, and prognostic.
Major changes to the AECC deﬁnition included:irect precipitating cause
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pulmonary edema or volume overload
PaO2/FiO2 ratio withP5 cm H2O positive end-expiratory
Pressure (PEEP)
00 Mild ARDS: 201–300
Moderate ARDS: 101–200
Severe ARDS: 6100
If none identiﬁed, then need to rule out cardiogenic edema
with additional data (e.g., echocardiography)
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umbrella term and replacing it with three levels of
ARDS severity based on PaO2/FiO2 measured with at
least 5 cm H2O of applied PEEP,
(2) Deﬁning ‘‘acute’’ as 67 days from the predisposing clin-
ical insult, and
(3) Eliminating pulmonary wedge pressure cutoff values
that discriminate ARDS from cardiogenic edema. The
Berlin criteria provide a slight improvement in predictive
ability for mortality (area under the curve [AUC] 0.577)
when compared to the AECC (0.536).
Frequency
The incidence of ARDS varies greatly, partly because of differ-
ing and changing deﬁnitions of this disease [8].
Within intensive care units, approximately 10–15% of
admitted patients and up to 20% of mechanically ventilated
patients meet criteria for ALI or ARDS [9–12]. The incidence
of ALI may be somewhat higher in the United States than in
other countries [13].
The incidence of ARDS may be decreasing. A prospective
cohort study from a single institution reported that the inci-
dence of ARDS decreased from 82.4 cases per 100,000 per-
son-years in 2001 to 38.9 cases per 100,000 person-years in
2008 [14]. This was attributable to a decline in hospital-
acquired ARDS, since the incidence of ARDS at hospital pre-
sentation did not change. These ﬁndings may reﬂect changes in
the delivery of care at this institution only; studies from other
institutions are necessary before it can be concluded that the
incidence of ARDS is declining in general.
Risk factors
A number of single-center prospective cohort studies that
enrolled patients at risk for ARDS have identiﬁed risk factors
for the development of ARDS (Table 3). Non-modiﬁable risk
factors for ARDS include a history of alcohol abuse [16], obes-
ity, and admission severity of illness (Acute Physiology andTable 3 Multivariable-adjusted predisposing conditions and clinica
[21].
Predisposing conditions
Shock
Aspiration
Aortic surgery
Emergency surgery
Cardiac surgery
Acute abdomen
Traumatic brain injury
Pneumonia
Risk modiﬁers
Obesity (body mass index >30)
Diabetes (only in sepsis; associated with decreased risk)
Hypoalbuminemia
FIO2 > 0.35
pH< 7.35
Tachypnea (respiratory rate > 30)Chronic Health Evaluation [APACHE] > 16) [15]. Prospective
studies have shown either no association [15] or a protective
association [16,17] between older age and ARDS development.
Potentially modiﬁable risk factors for ARDS include increased
use of red blood cell transfusion [18], admission hypoprotein-
emia [17], failure to achieve resuscitation goals within 6 h of
septic shock onset, and failure to provide adequate antibiotics
within 3 h of septic shock [19]. Interestingly, patients with
diabetes have approximately half the risk of developing ARDS
as at-risk patients without diabetes [20]. Determining mecha-
nisms for these risk factors may allow for the development
of therapies that prevent ARDS.
Outcome
The outcome for ALI and ARDS has improved during the
past two decades with mortality rates of 35–45% [22].
However, it is not clear whether this reduction is due to any
speciﬁc intervention because these improvements occurred
before the large NIH trials [23].
Mortality
ALI and ARDS are associated with appreciable mortality,
with estimates ranging from 26% to 58 % [24,25]. The under-
lying cause of the ALI or ARDS is the most common cause of
death among patients who die early [26,27]. In contrast, noso-
comial pneumonia and sepsis are the most common causes of
death among patients who die later in their clinical course [28].
Patients uncommonly die from respiratory failure [25].
Numerous studies suggest that survival has improved over
time [27,29]. As an example, an observational study of 2451
patients who had enrolled in ARDSNet randomized trials
found a fall in mortality from 35% to 26% between 1996
and 2005 [30].
Although encouraging, several issues should be considered
with respect to trends in ARDS-related mortality:
The improved mortality may be attributable to patients
who have ARDS related to risk factors other than sepsis, such
as trauma [27]. To the extent that mortality has decreased, thel risk factors for acute lung injury (Lung injury prediction study)
Proportion of patients with condition who develop ARDS
18%
17%
17%
17%
10%
9%
9%
8%
Odds ratio for developing ARDS
1.75
0.55
1.58
2.77
1.73
1.99
228 A.A. Mahrous et al.reasons are uncertain. Likely causes include better supportive
care and improved ventilatory strategies, such as low tidal vol-
ume ventilation [30–32].
Predictors.Many studies have sought to identify factors during
the acute illness that predict mortality. Such factors can be cat-
egorized as patient-related, disease-related, or treatment-related.
No single factor has proven to be superior to the others.
Patient-related. Older patients appear to be at an increased risk
of death [30,18]. This was illustrated by a multicenter cohort
study that followed 1113 patients with ALI for 15 months
[33]. The mortality rate increased progressively with age, rang-
ing from 24% among patients 15–19 years of age to 60%
among patients 85 years of age or older. The overall mortality
rate was 41%.
Disease-related. Disease-related predictors of mortality include
failure of oxygenation to improve, increased dead space, infec-
tion, high severity of illness score, non-traumatic cause of the
ARDS, and certain biomarkers and gene polymorphisms.
In recent years, a number of studies have focused on deﬁn-
ing the role of plasma mediators or markers of inﬂammation
and their association with phenotype and outcome in this dis-
ease [34–36]. However, despite the body of literature connect-
ing CRP with prognosis in other diseases little is known about
the characteristics of CRP levels in patients with ARDS and
acute lung injury (ALI).
C-reactive protein (CRP). C-reactive protein (CRP) is an acute
phase protein produced primarily from the liver and is stimu-
lated by the release of cytokines, such as interleukin-6 [37].
CRP is a marker of systematic inﬂammation that is elevated
during a wide variety of diseases [38,39], and is widely used
at numerous emergency departments. The severe inﬂammatory
process of the lung in ALI/ARDS patients occurs in response
to various etiologies, including pulmonary or extrapulmonary
injury [40].
Although there have been a few reported studies regarding
CRP levels [34,41] in critically ill patients with ALI/ARDS, the
prognostic value of CRP for these conditions has not been
determined. In addition, in vitro and animal model studies
have suggested that CRP may play a pathogenic role by inhib-
iting neutrophil chemotaxis or modulating vascular permeabil-
ity in ways that could potentially be protective in patients with
these diseases [42–44].
Several studies have sought factors during acute illness that
predict long-term sequelae [45,46]. Persistent symptoms one
year after recovery correlate with duration of mechanical ven-
tilation and the lowest static thoracic compliance during acute
illness [45].
Abnormal lung function one year after recovery correlates
with the following factors measured during acute illness: low-
est static thoracic compliance, mean pulmonary artery pres-
sure, positive end-expiratory pressure (PEEP), initial
intrapulmonary shunt fraction, and requirement of an FiO2
>0.6 for more than 24 h [47,48].
A better functional outcome at one year correlates with
absence of steroid treatment, absence of illness acquired during
ICU stay, and rapid resolution of multiple organ failure and
lung injury [46]. There is no known correlation betweenventilatory strategies and either long-term pulmonary function
or health-related quality of life [49,50].
Aim of the work
1. To examine plasma level of C-reactive protein (CRP) in
patients with acute lung injury (ALI) and its relationship
to outcome and severity of illness.
Patients and methods
The study was carried out on 100 consecutive patients, who
were admitted to both the Emergency and Critical Care
Medicine Departments in Alexandria Main University Hospital.
Approval of the medical ethics committee of Alexandria
Faculty of Medicine, and an informed consent from the patients
or their next of kin were taken before conducting the study.
Inclusion criteria were:
All patients who aged >18 years who have one or more of
the acute lung injury (ALI) predisposing conditions (Table 4)
will be included in the study.
Acute lung injury will be deﬁned based on the standard def-
inition according to the American–European consensus con-
ference [3]. The deﬁnition is based on:
1. Acute onset of an insult known to cause ALI,
2. Chest radiograph appearance,
3. Ratio of partial pressure of oxygen in arterial blood to frac-
tion of inspired oxygen (PaO2/FiO2) (hypoxic index),
4. Assessment of left atrial ﬁlling and pressure by means of a
wedged pulmonary artery catheterization or clinical
assessment.
Exclusion criteria were:
1. Acute lung injury or pulmonary edema already present at
the time of hospital admission.
2. Admitted for comfort or hospital care only.
3. Patients admitted for cardiac telemetry, coronary care unit,
and low risk elective surgery.
4. Hospital readmission.
5. Hospital transfer.
6. Patients less than 18 years of age.
All patients who will have any acute lung injury (ALI) risk
factors before or 6 h after hospital admission will be subjected
to lung injury predictive score (LIPS).
Patients will be categorized into two groups based on lung
injury predictive score (LIPS):
1. Group I: (LIPS > 3) patients at high risk of developing
acute lung injury.
2. Group II: (LIPS 6 3) patients at low risk of developing
acute lung injury.
Patients who develop acute lung injury (ALI) with fulﬁll-
ment of the criteria of acute lung injury (ALI) based on the
standard deﬁnition according to the American–European
consensus conference will be examined for C-reactive protein
levels in serum collected within 48 h after fulﬁllment of criteria.
Table 4 Predisposing conditions and modiﬁers available before or within 6 h after hospital admission used to calculate the lung injury
prediction score (LIPS) [51].
Risk factors Measurement Deﬁnition
Pneumonia Yes/No Consensus conference [52]
Sepsis Yes/No SCCM-ACCP deﬁnition [53]
Pancreatitis Yes/No Practice guidelines in acute pancreatitis [54]
Aspiration (pre-admission) Yes/No Inhalation of food or gastric contents [55]
High risk trauma Lung contusion, smoke inhalation,
near-drowning, multiple bone, brain
injury
From Derdak [56]
High risk surgery Aortic vascular, spine, thoracic, acute
abdomen,
From Arozullah et al. [57,58]
Shock Emergency Shock index; <1,
>1 < 1.5, >1.5
Heart rate (HR) divided by systolic blood pressure (SBP)
Risk modiﬁers
Alcohol use Yes/No, amount (number of drinks a
week)
More than 2 drinks per day or a history of alcohol-related
illness or admission [15,59]
Smoking Never/former/current/number of
pack-years
Substance abuse and mental health
Diabetes mellitus Yes/No Diabetes care 2009 [20]
Interstitial lung disease Yes/No ATS-ERS consensus classiﬁcation of IIP [60]
Chemotherapy Yes/No Custom, cancer chemotherapeutic drugs during the
6 months prior to hospitalization
Tachypnea (respiratory rate > 30 cycle/min) Based on the worst value during the ﬁrst 6 h
Hypoalbuminemia Serum albumin <3.5 g/dl, the absence of measurement
considered normal
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following:
1. Demographic data: age and sex.
2. History taking: as regards the risk factors for acute lung
injury.
3. Complete clinical examination.
4. Routine laboratory investigations including: complete
blood count, serum sodium, serum potassium, serum
creatinine, blood urea, random blood sugar, total pro-
tein, serum albumin, and serum bilirubin.
5. Electrocardiogram (ECG) on admission and when
needed.
6. Chest X-ray on admission, every 24 h and when needed.
7. Arterial blood gas analysis through direct arterial punc-
ture or inserted arterial line for measurement of PaO2 to
calculate (PaO2/FiO2).
8. Continuous arterial oxygen saturation (SpO2) monitor-
ing by pulse oxymetry (Dash 4000 monitor, General
Electric Medical System, Nell Cor) to detect any acute
changes in oxygen saturation.
9. Continuous end tidal carbon dioxide (PET CO2) moni-
toring using capnography (Dash 4000 monitor, General
Electric Medical System, Marquette) to detect any acute
changes in mechanical ventilation.
10. Hemodynamic parameters:
* Continuous monitoring of heart rate and mean sys-
tolic blood pressure using bedside monitor (Dash 4-
000 monitor, General Electric Medical System) and
this will be recorded every hour.
* Central venous pressure monitoring (cm H2O) every
6 h, will be measured during connection to mechan-
ical ventilator.11. Calculation of lung injury predictive score on admission.
12. Sampling for level of CRP in serum collected within 48 h
of developing acute lung injury (ALI).
All patients fulﬁlling the criteria of acute lung injury (ALI)
included in the study will be mechanically ventilated according
to the same protocol recommended by ARDS network lung
protective strategy [32].
All mechanically ventilated patients will be managed with
the same protocol for sedation and ﬂuid management.
Outcome variables:
1. Development of acute lung injury (ALI).
2. Duration of mechanical ventilation.
3. Intensive care unit (ICU) length of stay.
4. Development of multi organ dysfunction (MODS).
5. Prognosis (complete recovery, recovery with residual com-
plications, and 28 day mortality).
Results
Demographic data
Gender
In our study most of our study population were male (64
patients) which represent 64% of our study population while
36% were female with sex distribution (male:female ratio) of
1.77:1 (Table 5).
Age
Age of patients in the study ranges between 18 and 90 years
with a mean of 48.38 ± 19.49 (Fig. 1).
Age
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N =100
Figure 1 Distribution of the studied cases according to age.
Table 6 Frequency of etiological factors of ALI.
ALI group
No. %
Pneumonia 9 60.0
Sepsis 9 60.0
Shock 8 53.4
Aspiration 3 20.0
High risk trauma 2 13.3
Pancreatitis 1 6.70
Table 7 Sex in relation to ALI development.
ALI development Total
Yes No
No. % No. % No. %
Sex
Male 10 66.70 54 63.50 64 64.00
Female 5 33.30 31 36.50 36 36.00
Total 15 100.00 85 100.00 100 100.00
v2 0.054
P 0.531
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Table 6 demonstrates the frequency and percentage of the dif-
ferent predisposing factors for ALI in our study:
Pneumonia and sepsis were the most frequent predisposing
factors for ALI in our study, accounting for 60% (9 patients)
of each. This was followed by shock accounting for 53.4% (8
patients). Other etiological factors include aspiration (3
patients), high risk trauma (2 patients) and pancreatitis (1
patient).
Table 7 shows the relationship between patient sex and
development of ALI: among 64 males constituting 64% of
all patients only 10 patients developed ALI and among 36
females constituting 36% of all patients only 5 patients devel-
oped ALI.
There was no statistically signiﬁcant relationship between
sex difference and development of ALI, (P= 0.531).
Table 8 shows the relation between LIPS risk factors and
CRP levels.
In patients with pneumonia who developed ALI, CRP lev-
els ranged between 50 and 190 with a mean of 90.29 ± 43.296.
There was no signiﬁcant relationship between pneumonia and
CRP levels in the study group (P= 0.848) (see Fig. 2). In
patients with sepsis who developed acute lung injury CRP
levels ranged between 65 and 233 with a mean of
110.56 ± 61.299. There was no signiﬁcant relationship
between sepsis and CRP levels in the study group (P= 0.114).
In patients with aspiration who developed ALI, CRP levels
ranged between 100 and 225 with a mean of 143.67 ± 70.501.
There was no signiﬁcant relationship between aspiration and
CRP levels in the study group (P= 0.310).
In patients with pancreatitis who developed ALI, CRP lev-
els were 107 and 225 with a mean of 143.67 ± 70.501. There
was no signiﬁcant relationship between pancreatitis and CRP
levels in the study group (P= 0.792).
In patients with trauma who developed ALI, CRP levels
were 35 and 225 with a mean of 130.00 ± 134.35. There was
no signiﬁcant relationship between trauma and CRP levels in
the study group (P= 0.652).
In patients with shock index > 1 6 1.5 who developed
ALI, CRP levels were 50 and 93 with a mean of
74.40 ± 20.369. In patients with shock indexP1.5 who devel-
oped acute lung injury CRP levels were 35 and 190 with a
mean of 112.75 ± 63.537. There was no signiﬁcant relation-
ship between shock index and CRP levels in the study group
(P= 0.325).
In patients with high RR >30 cycle/min who developed
ALI, CRP levels were 35 and 233 with a mean of
83.97 ± 49.665. There was no signiﬁcant relationship between
high RR and CRP levels in the study group (P= 0.116).
In patients with low serum albumin <3.5 who developed
ALI, CRP levels were 35 and 225 with a mean ofTable 5 Distribution of the studied cases according to gender.
Gender Pt. No. %
Male 64 64
Female 36 36
Male to female ratio 1.7786.82 ± 49.858. There was no signiﬁcant relationship between
serum albumin and CRP levels in the study group (P= 0.306).
In patients with smoking who developed ALI, CRP levels
were 76 and 190 with a mean of 119.75 ± 48.992. There was
no signiﬁcant relationship between smoking and CRP levels
in the study group (P= 0.757).
In patients with diabetes who developed ALI, CRP levels
were 66 and 232 with a mean of 101.80 ± 134.35. There was
no signiﬁcant relationship between diabetes and CRP levels
in the study group (P= 0.655).
Table 9 illustrates the relationship between CRP levels and
the 2ry end point: CRP levels were the highest in patients with
complete recovery ranging between 190 and 233 with a mean
Table 8 CRP in relation to risk factors for ALI.
Minimum Maximum Mean Std. deviation F Sig.
Pneumonia
Yes 50 190 90.29 43.296 .038 .848
No 35 233 96.00 70.920
Total 35 233 111.43 59.332
Sepsis
Yes 65 233 110.56 61.299 2.867 .114
No 35 107 65.60 24.191
Total 35 233 111.43 59.332
Aspiration
Yes 100 225 143.67 70.501 1.116 .310
No 35 233 103.38 56.767
Total 35 233 111.43 59.332
Pancreatitis
Yes 107 107 107.00 .072 .792
No 35 233 91.54 55.497
Total 35 233 111.43 59.332
Trauma
Yes 35 225 130.00 134.35 .213 .652
No 50 233 108.58 50.364
Total 35 233 111.43 59.332
Shock index
>1 6 1.5 50 93 74.40 20.369 1.234 .325
P1.5 35 190 112.75 63.537
<1 75 233 131.84 67.725
Total 35 233 111.43 59.332
RR> 30
Yes 35 233 83.97 49.665 2.840 .116
No 107 190 148.50 58.690
Total 35 233 111.43 59.332
Albumin < 3.5
Yes 35 233 86.82 49.858 1.135 .306
No 70 190 130.00 84.853
Total 35 233 111.43 59.332
Smoking
Yes 76 190 119.75 48.992 .100 .757
No 35 233 108.41 64.580
Total 35 233 111.43 59.332
Diabetes
Yes 66 233 101.80 73.363 .209 .655
No 35 190 87.96 44.839
Total 35 233 111.43 59.332
Figure 2 Endpoint in relation to CRP.
Predictive value of C-reactive protein 231of 211.5 ± 30.406, modest in patients who recovered with
residual complications ranging between 107 and 120 with a
mean of 111.33 ± 7.506, and lowest in patients who died rang-
ing between 35 and 106 with a mean of 79.55 ± 24.007.
Higher CRP levels were signiﬁcantly associated with better
survival (P= 0.000).
Table 10 illustrates the correlation between CRP levels and
both mechanical ventilation days and ICU stay:
There was an inverse relationship between CRP levels and
mechanical ventilation days while ICU stay increases as the
CRP levels increase.
Relationships between CRP levels and both mechanical
ventilation days and ICU stay are statistically non signiﬁcant
(P= 0.710 and 0.801 respectively).
Table 9 Endpoint in relation to CRP level.
Minimum Maximum Mean Std. deviation F Sig.
CRP Recovered 190 233 211.50 30.406 28.194 .000
Residual complication 107 120 111.33 7.506
Died 35 106 79.55 24.007
Total 35 233 103.50 50.336
Table 10 Correlations between CRP, MV days and ICU stay.
CRP
MV days r .105
p .710
N 15
ICU stay r .071
p .801
N 15
Correlation is signiﬁcant at the 0.01 level (2-tailed).
232 A.A. Mahrous et al.Table 11 illustrates the relationship between CRP levels and
development of MODS.
CRP levels were lower in patients who developed MODS
ranging between 35 and 106 with a mean of 76.6 ± 28.778
and were higher in patients who didn’t develop MODS ranging
between 66 and 233 with a mean of 111.43 ± 59.332. This rela-
tionship was not statistically signiﬁcant (P= 0.060).
Discussion
ALI can represent a devastating pulmonary process associated
with increased length of stay, costs, and long-term poor out-
comes [61,62]. Moreover, it represents a disease that has the
potential to impart a burden across a younger and healthier
population than previously recognized [63].
The incidence of ALI in this study was 15%, this ﬁnding
was supported by Trillo-Alvarez et al. [64] in their study
whereof 409 patients with at least one predisposing condition
at the time of hospital admission, out of 1707 Olmsted County
admissions who required ICU care during the study period, 68
(17%) developed ALI/ARDS. While the incidence was lower
in other studies like: Gajic et al. [65] where the incidence was
6.8% and Elie-Turenne et al. [66] where the overall incidence
was 7%. This can be explained by the type of collected patients
where in the current study and in the study of Trillo-Alvarez
et al. the study was done in patients who required ICU admis-
sion while in the other two studies with the lower incidence rate
they were done to inpatient, ICU and ER patients.
Mean age in the current study was 48 years, in those who
developed ALI it was 51.9 years and in those who didn’t
develop ALI it was 47.4 years, there was no statistically signif-
icant difference between the two groups (P= 0.410). WhileTable 11 MODS in relation to CRP.
Minimum Maximum
CRP Yes 35 106
No 66 233
Total 35 233some previous studies reported an increased risk of
ALI/ARDS in the elderly [67–69], other studies have not
conﬁrmed this association [70–72]. It could be argued that
elderly patients seem to have an increased incidence of
ALI/ARDS as they tend to have more sepsis, pneumonia
and aspiration, and require more medical interventions.
However, in patients admitted to the hospital with a risk factor
(pneumonia or sepsis), age does not seem to increase the risk of
ALI/ARDS development. Indeed, recent work implies that
incidence of ALI/ARDS due to community-acquired pneumo-
nia is lower in patients aged P85 years [70].
In the current study there was no signiﬁcant difference with
regard to patient gender as a risk factor to develop ALI. This
ﬁnding was supported by Ferguson et al. [73], Trillo-Alvarez
et al. [64] and Elie-Turenne et al. [66] in their studies.
Regarding the risk factors for ALI development, in our
study the incidence was higher in pneumonia (60% of the
ALI group), sepsis (60% of the ALI group), shock (53% of
the ALI group) followed to a lesser degree by aspiration
(20% of the ALI group) and trauma (13% of the ALI group),
which is consistent with the results of the previous studies.
Review articles on ALI list dozens of potential risk factors
for ALI including drugs, burns, inhalation injury, pancreatitis,
amniotic ﬂuid embolism, and transfusion. In most cohort stud-
ies and clinical trials, the majority of cases are caused by pneu-
monia followed by extra pulmonary sepsis, traumatic injuries,
and shock [74,75].
Studies of risk factors for ALI are limited by varying
degrees of rigor in establishing the deﬁnition of the risk factor.
These studies are challenging because they require not only
detailed data on the patients with ALI but on patients at risk
of the syndrome who do not acquire it. Furthermore, the asso-
ciation between risk factor and ALI as well as the association
between risk factor and death may be distorted by transfer and
referral patterns in single center studies.
The likelihood of ALI development depends not only on
speciﬁc risk factors (from 5% with elective cardiopulmonary
bypass [76] to 40% in patients with septic shock [19]), but also
on the presence of speciﬁc risk modiﬁers.
These risk modiﬁers include alcohol abuse [76,19], hypoal-
buminemia [17,18], tachypnea [18,19], chemotherapy [19,77]
and diabetes mellitus [18,78], although whether these factors
are independent of one another is unclear. This was consistent
with the results of our study except for alcohol abuse andMean SD F Sig.
76.60 28.778 4.246 .060
134.66 64.236
111.43 59.332
Predictive value of C-reactive protein 233chemotherapy as there were no or too few people with these
risk modiﬁers in the study population.
We found that among 15 patients with ALI, plasma CRP
levels were signiﬁcantly higher among patients who survived
>28 days, mean CRP levels among completely recovered
patients were 211.5 mg/dl (P= 0.000), we had excluded one
patient from the statistical analysis as the cause of death was
tension pneumothorax as a complication of tracheostomy
operation. In keeping with that ﬁnding, there was an inverse
association between increasing CRP levels and 28-day mortal-
ity and requirement for mechanical ventilation. This ﬁnding is
consistent with Bajwa et al. [79] in a study done on 177 patients
with ARDS where 60-day mortality and days of mechanical
ventilation were lower among patients with higher CRP levels.
In our study we found also that CRP levels were lower
among patients who developed MODS during hospital stay
with a mean CRP value of 76.6 mg/dl (P= 0.06). This ﬁnding
was also compatible with Bajwa et al. [79] in their study. Any-
how this ﬁnding failed to reach signiﬁcance at a statistical test,
this may be attributed to the small sample size.
In another study, Kew et al. [80] report that patients with
respiratory distress (an inﬂammatory pathology in its genesis)
and elevated levels of CRP show better prognosis compared to
patients with ARDS with lower CRP values. This ﬁnding was
also compatible with the results of the current study regarding
mortality and duration of mechanical ventilation.
In contradict with Bajwa et al. [79] ﬁndings, length of ICU
stay was directly related to the CRP level: a ﬁnding consistent
with many other studies like Bhattacharya et al. [81], a pro-
spective cohort study on 30 patients >18 years who required
mechanical ventilation and in Lobo et al. [38], a prospective
cohort study on 313 patients admitted to the ICU during the
4-month study period.
In the current study there was a signiﬁcant relationship
between ICU length of stay and the ﬁnal outcome
(P= 0.004). Shorter ICU stay was associated with better
28 day survival. This ﬁnding is supported by Soppa et al.
[82] on 2250 patients undergoing adult cardiac surgery between
October 2008 and October 2010 who stayed in an ICU for 5–
10 days (Group A) or >10 days (Group B) were studied. They
found that patients who have a prolonged ICU stay
(>10 days) following cardiac surgery have high early and late
mortalities.
In the current study there was a signiﬁcant relationship
between duration of mechanical ventilation and the ﬁnal out-
come (P= 0.032). Mean days of mechanical ventilation in
completely recovered patients was 6 ± 1.414 days, longer
durations of mechanical ventilation were associated with less
favorite prognosis. This ﬁnding was compatible with Feng
et al. [83]. This study suggests that age and duration of MV
are strongly associated with mortality and post hospital
disposition.
C-reactive protein is a biomarker in common clinical use to
delineate the activity of a host of inﬂammatory conditions such
as sepsis, cardiovascular disease and rheumatological disor-
ders. Patients with sepsis-induced acute respiratory distress
syndrome (ARDS) have elevated levels of CRP in both plasma
and the bronchoalveolar lavage (BAL) [84,85]. Furthermore,
patients who survived acute lung injury tended to have more
CRP levels in their blood and BAL ﬂuid than those patients
who died [80]. Elevation in serum CRP may be a mechanism
to control acute inﬂammation by down-regulating someneutrophil functions. Serum from high-risk and ARDS
patients has signiﬁcantly less neutrophil chemotactic activity
than serum from normal subjects [80].
Although clinical data regarding CRP and lung injury are
lacking, a protective role is biologically plausible. Neutrophils
are known to accumulate in the lungs of patients with ARDS
and are thought to play a pivotal role in lung injury [86]. To
cause injury, neutrophils must be recruited to the lung, primar-
ily through the effect of chemoattractant molecules [87], and
then activated to release a variety of injurious substances
[88]. Then, delayed apoptosis prolongs the lifespan of neutro-
phils in the lung and perpetuates injury leading to ALI/ARDS
[89].
CRP does appear to play an important role in neutrophil
chemotaxis, but its role may be more complex than serving
to act solely as a chemoattractant; more than 25 years ago,
Buchta and colleagues [90] showed that CRP stimulated che-
motaxis at lower concentrations but inhibits it, along with
other characteristic neutrophil functions, at higher concentra-
tions. These data appear to establish a basis for our ﬁndings
that CRP may play a protective role at high concentrations
without contradicting other studies suggesting an association
between CRP and worse outcomes. Patients in many of these
studies [90,91] typically have CRP levels much lower than
those observed in our critically ill population.
Limitations
The main limitation of the study was the limited number of
patients, further studies are recommended in the future spe-
cially to evaluate the prognostic value of CRP in patients with
ALI.
The other limitation was that our study was a single center
study.
Conﬂict of interest
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